advancing innovation to save lives

New fact sheet series: R&D across health areas

GHTC released a new fact sheet series that examines the role of R&D in driving progress across different global health areas. Each fact sheet provides an overview of R&D for a specific disease or health area, including examples of past research successes, key missing tools, promising products in development, and how the US government is contributing to R&D efforts.
Learn More

New resource: COVID-19 R&D Tracker

GHTC has created a new resource tracking the current state of R&D efforts to combat COVID-19. The tracker, which will be updated regularly, includes information on R&D efforts supported by the US government, multilateral institutions, and GHTC member organizations.

Member Spotlight: Treatment Action Group

On March 24, World TB Day, Treatment Action Group is working alongside We Are TB, the National TB Controllers Association, and TB Alliance to organize their annual TB Survivor Hill Day; TB survivors and their advocacy partners will travel to Washington, DC from across the country to advocate for continued and increased funding for TB programs including vital US government TB research & development initiatives. 
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We bring together more than 25 nonprofit organizations, academic institutions, and aligned businesses to advance policies to accelerate the creation of new drugs, vaccines, diagnostics, and other tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.

Learn more

PATH/Matthew Dakin
GHTC joins civil society in urging G20 leaders to strengthen R&D to meet critical health challenges

GHTC joined civil society in urging G20 policymakers at today’s C20 meeting with the G20 Health Working Group to strengthen R&D to meet urgent health challenges, including achieving universal health coverage and combating antimicrobial resistance and other health threats. 

Learn More

PATH/ Patrick McKern
GHTC joins InterAction in calling on G7 to prioritize health

GHTC joined the humanitarian and development coalition InterAction in calling on G7 foreign ministers to prioritize health on the 2020 G7 agenda. The coalition released a policy report, including a section on health co-authored by GHTC, which urges the G7 to investment in R&D for new health tools.

View All News & Events
PATH/Doune Porter
President signs spending bill boosting funding for global health

On February 15, President Trump signed into law a bipartisan spending bill—averting another partial government shutdown and ensuring full-year funding for the government for the remainder of fiscal year 2019. The months-long saga ended with some great news for global health and research and development.

Read More
PATH/Algy Amad
Research Roundup: Pregnant women in DRC to be given Ebola vaccine, releases of genetically modified mosquitoes in high-security lab, and CRISPR may help against viruses for which no vaccine exists

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide